NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Nanjing Vishee Medical Technology Co Ltd (SHG: 688580)
688580 Technical Analysis
4
As on 2nd Apr 2025 688580 STOCK Price closed @ 41.04 and we RECOMMEND Sell for LONG-TERM with Stoploss of 63.20 & Strong Sell for SHORT-TERM with Stoploss of 92.95 we also expect STOCK to react on Following IMPORTANT LEVELS. |
688580STOCK Price
Open | 34.18 | Change | Price | % |
High | 41.04 | 1 Day | 6.84 | 20.00 |
Low | 34.00 | 1 Week | 7.31 | 21.67 |
Close | 41.04 | 1 Month | 9.46 | 29.96 |
Volume | 6119402 | 1 Year | -47.40 | -53.60 |
52 Week High 98.74 | 52 Week Low 20.70 |
SHG China Most Active Stocks
600705 | 3.47 | 0.29% |
601288 | 5.17 | 0.78% |
603169 | 8.69 | 6.76% |
601398 | 6.85 | 0.74% |
603300 | 10.56 | 4.45% |
600126 | 11.47 | 0.09% |
600095 | 8.24 | 7.71% |
600789 | 11.15 | 0.18% |
600157 | 1.45 | -0.68% |
601818 | 3.81 | 1.87% |
SHG China Top Gainers Stocks
SHG China Top Losers Stocks
688580 Daily Charts |
688580 Intraday Charts |
Whats New @ Bazaartrend |
688580 Free Analysis |
|
688580 Important Levels Intraday
RESISTANCE | 54.61 |
RESISTANCE | 50.26 |
RESISTANCE | 47.57 |
RESISTANCE | 44.88 |
SUPPORT | 37.20 |
SUPPORT | 34.51 |
SUPPORT | 31.82 |
SUPPORT | 27.47 |
688580 Forecast April 2025
4th UP Forecast | 82.7 |
3rd UP Forecast | 69.34 |
2nd UP Forecast | 61.08 |
1st UP Forecast | 52.82 |
1st DOWN Forecast | 29.26 |
2nd DOWN Forecast | 21 |
3rd DOWN Forecast | 12.74 |
4th DOWN Forecast | -0.62 |
688580 Weekly Forecast
4th UP Forecast | 53.55 |
3rd UP Forecast | 49.54 |
2nd UP Forecast | 47.06 |
1st UP Forecast | 44.58 |
1st DOWN Forecast | 37.50 |
2nd DOWN Forecast | 35.02 |
3rd DOWN Forecast | 32.54 |
4th DOWN Forecast | 28.53 |
688580 Forecast2025
4th UP Forecast | 195.64 |
3rd UP Forecast | 146.06 |
2nd UP Forecast | 115.41 |
1st UP Forecast | 84.77 |
1st DOWN Forecast | -2.69 |
2nd DOWN Forecast | -33.33 |
3rd DOWN Forecast | -63.98 |
4th DOWN Forecast | -113.56 |
Nanjing Vishee Medical Technology Co Ltd ( SHG China Symbol : 688580 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
688580 Other Details
Segment | EQ | |
Market Capital | 6074654720.00 | |
Sector | Healthcare | |
Industry | Medical Devices | |
Offical website | > echo $website ; ?> |
688580 Address
![]() |
688580 Latest News
688580 Business Profile
Nanjing Vishee Medical Technology Co., Ltd. develops and manufactures medical rehabilitation devices in China. It offers pelvic floor and postpartum, neurological, and mental rehabilitation solutions; and bio-stimulation feedback devices, magnetic stimulators, etc. The company's solutions cover markets, such as electrical and magnetic stimulation, electrophysiology, and other technical directions. It offers its products through dealers, sales network, and distributors to hospitals, and terminal medical and professional institutions. The company was founded in 2001 and is based in Nanjing, China. Address: No. 19, Ningshuang Road, Nanjing, China, 210012
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service